Literature DB >> 34406378

Non-conventional Versus Conventional Strictureplasties for Crohn's Disease. A Systematic Review and Meta-analysis of Treatment Outcomes.

G Bislenghi1, F Sucameli1, S Fieuws2, M Ferrante3, J Sabino3, A Wolthuis1, S Vermeire3, A D'Hoore1.   

Abstract

BACKGROUND: Strictureplasties [SXP] represent an alternative to bowel resection in Crohn's disease [CD]. Over the years, there has been growing interest in the role of non-conventional SXP for the treatment of extensive CD. A systematic review was performed on complications and recurrence following conventional and non-conventional SXP.
METHODS: The available literature was screened according to the PRISMA statement, until June 2020. Results were categorised into three groups: studies reporting on conventional SXPs; studies with a mixed cohort of conventional and non-conventional SXPs [% non-conventional SXPs ≤15%]; and studies reporting on non-conventional SXPs. Considered endpoints were postoperative complications and overall and SXP site-specific surgical recurrence. Random-effect meta-analysis and meta-regression were used to obtain and compare combined estimates between groups.
RESULTS: A total of 26 studies for a total of 1839 patients with CD were included. The pooled postoperative complication rates were was 15.5% (95% confidence interval [CI] 11.2%-20.3%), 7.4% [95% CI 0.2%-22.9%], and 19.2% [95% CI 5-39.6%] for the three groups, respectively. The rates of septic complications were 4% [95% CI 2.2%-6.2%], 1.9% [95% CI 0.4%-4.3%], and 4.2% [95% CI 0.9%-9.8%], respectively. Cumulative overall surgical recurrence rates were 27.5% [95% CI 18.5%-37.6%], 13.2% [95% CI 8.6%-18.7%], and 18.1% [95% CI 6.8%-33.3%]; and SXP site-specific surgical recurrence rates were 13.2% [95% CI 6.9%-21.2%], 8.3% [95% CI 1.6-19.3%], and 8.8% [95% CI 2.2%-19%], respectively. Formal comparison between the groups revealed no differences.
CONCLUSIONS: Non-conventional SXP did not differ from conventional SXP with respect to safety and long-term recurrence. Consistent heterogeneity was observed and partially limits the conclusions of this study.
© The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; meta-analysis; morbidity; recurrence; side-to-side isoperistaltic strictureplasties; strictureplasties; surgery

Mesh:

Year:  2022        PMID: 34406378     DOI: 10.1093/ecco-jcc/jjab146

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  2 in total

Review 1.  Intestinal strictures in Crohn's disease: a 2021 update.

Authors:  Xiaoxuan Lin; Yu Wang; Zishan Liu; Sinan Lin; Jinyu Tan; Jinshen He; Fan Hu; Xiaomin Wu; Subrata Ghosh; Minhu Chen; Fen Liu; Ren Mao
Journal:  Therap Adv Gastroenterol       Date:  2022-06-21       Impact factor: 4.802

2.  Perforating and nonperforating indications in repeated surgeries for Crohn's disease.

Authors:  Wei-Song Shen; Xiao-Hui Huang; Rui-Qing Liu; Chen-Yang Li; Yi Li; Wei-Ming Zhu
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.